Cas:186589-76-4 5-Chloro-2-fluorophenol manufacturer & supplier

We serve Chemical Name:5-Chloro-2-fluorophenol CAS:186589-76-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

5-Chloro-2-fluorophenol

Chemical Name:5-Chloro-2-fluorophenol
CAS.NO:186589-76-4
Synonyms:5-Chloro-2-fluorophenol;Phenol, 5-chloro-2-fluoro-;2-Fluoro-5-chlorophenol;Phenol,5-chloro-2-fluoro
Molecular Formula:C6H4ClFO
Molecular Weight:146.547
HS Code:2908199090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:187.1±20.0 °C at 760 mmHg
Density:1.4±0.1 g/cm3
Index of Refraction:1.548
PSA:20.23000
Exact Mass:145.993469
LogP:2.58

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 5-Chloro-2-fluorophenol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Phenol,5-chloro-2-fluoro physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Fluoro-5-chlorophenol Use and application,Phenol,5-chloro-2-fluoro technical grade,usp/ep/jp grade.


Related News: Under the terms of this agreement, Inceptua will support Onconova through the pre-approval provision of intravenous rigosertib initially into a number of countries including: Australia, Denmark, Finland, France, Ireland, Italy, the Netherlands, Portugal, South Africa, Spain, and the UK. 5-Chloro-2-fluorophenol manufacturer Under the terms of this agreement, Inceptua will support Onconova through the pre-approval provision of intravenous rigosertib initially into a number of countries including: Australia, Denmark, Finland, France, Ireland, Italy, the Netherlands, Portugal, South Africa, Spain, and the UK. 5-Chloro-2-fluorophenol supplier In approving the first new Alzheimer’s drug in nearly 20 years, the U.S. Food and Drug Administration is taking its biggest risk yet with a strategy that allows new therapies onto the market without strong evidence that they work, regulatory and scientific experts say. 5-Chloro-2-fluorophenol vendor The fine and functional chemicals sector provides new growth drivers. 5-Chloro-2-fluorophenol factory In approving the first new Alzheimer’s drug in nearly 20 years, the U.S. Food and Drug Administration is taking its biggest risk yet with a strategy that allows new therapies onto the market without strong evidence that they work, regulatory and scientific experts say.